Differences in the Korea Acute Myocardial Infarction Registry Compared with Western Registries

Area of Science:

• Cardiology
• Public Health
• Clinical Research

Background:

• The Korea Acute Myocardial Infarction Registry (KAMIR) is the inaugural nationwide registry for acute myocardial infarction (AMI) in Korea.
• It captures current therapeutic strategies and management practices for AMI.

Purpose of the Study:

• To analyze risk factors, treatment responses, and clinical outcomes in Korean AMI patients.
• To evaluate the effectiveness and safety of various treatments, including percutaneous coronary intervention (PCI) with drug-eluting stents (DES), triple antiplatelet therapy, and statin therapy.
• To compare the predictive value of the KAMIR score with existing risk scores (TIMI, GRACE) for long-term mortality.

Main Methods:

• Analysis of data collected through the KAMIR nationwide registry.
• Comparison of clinical characteristics, treatment patterns, and outcomes among different patient subgroups.
• Evaluation of the efficacy and safety of interventional procedures and pharmacotherapies.
• Comparative analysis of risk prediction scores.

Main Results:

• High incidence of ST-elevation myocardial infarction (STEMI) and low prevalence of dyslipidemia with specific lipid profiles (high triglycerides, low HDL).
• High rates of PCI for both STEMI and non-ST-elevation myocardial infarction (NSTEMI), with widespread use of DES, showing safety and efficacy.
• Triple antiplatelet therapy (aspirin, clopidogrel, cilostazol) and statin therapy demonstrated effectiveness in preventing adverse outcomes, even in complex cases like cardiogenic shock.
• The KAMIR score exhibited superior predictive value for long-term mortality compared to TIMI and GRACE scores.

Conclusions:

• The KAMIR registry provides crucial insights into the distinct characteristics of AMI in Korea.
• Current therapeutic approaches, including PCI with DES and specific antiplatelet and statin regimens, are effective and safe.
• The KAMIR score is a valuable tool for risk stratification in AMI patients, potentially improving long-term outcomes and guiding future guidelines for Asian populations.